Standout Papers
- Subclinical Atrial Fibrillation and the Risk of Stroke (2012)
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation (2011)
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial (2010)
Immediate Impact
2 from Science/Nature 179 standout
Citing Papers
Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials
2023 Standout
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association
2022 Standout
Works of Sean Yang being referenced
Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
2012
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
2010 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sean Yang | 5184 | 2103 | 739 | 20 | 5.5k | |
| Cees B. de Vos | 3898 | 1282 | 588 | 23 | 4.2k | |
| Naveen Deenadayalu | 3530 | 1515 | 659 | 11 | 3.9k | |
| Kathleen A. Phillips | 5384 | 1094 | 800 | 13 | 5.9k | |
| Maria I. Aguilar | 3749 | 1380 | 1241 | 36 | 4.5k | |
| Palle Petersen | 4042 | 1582 | 1159 | 54 | 5.7k | |
| Julie B. Shea | 3690 | 854 | 439 | 34 | 4.1k | |
| Alan K. Jacobson | 4243 | 2133 | 457 | 36 | 5.4k | |
| Amit Parekh | 7961 | 3744 | 1282 | 28 | 8.7k | |
| Ziad Hijazi | 3902 | 1278 | 690 | 88 | 4.6k | |
| Jesper Lindhardsen | 3056 | 903 | 1018 | 65 | 6.5k |
All Works
Loading papers...